Abstract
The development and early distribution of the COVID-19 vaccine was both a singular achievement and missed opportunity. In this paper, I argue that the consensus regarding the goals of an effective and morally responsible vaccine distribution program were often eschewed in favor of a reversion to the problematic pre-pandemic healthcare distribution practices. I examine the goals of vaccine planning in terms of the public health, economic and social impacts of a distribution plan against the “first come, first served” strategies that were ultimately employed. I maintain that the failure to implement a coherent top- -down vaccine policy resulted in a proliferation of vaccine distribution programs that undermined efforts to combat the virus while also increasing pre-existing inequities in the healthcare system. The distribution of the vaccine according to a phased rollout strategy for individual groups often limited access to the vaccine for those most likely to suffer the worst outcomes of the disease. Future pandemic planning must learn from these outcomes and employ new technologies to limit the contagion and target at-risk groups most effectively.
Reference38 articles.
1. Alam, S. T., Ahmed, S., Ali, S. M., Sarker, S., Kabir, G., & Ul-Islam, A. (2021). Challenges to COVID-19 vaccine supply chain: Implications for sustainable development goals. International Journal of production economics, 239, 108193. https://doi.org/10.1016/j.ijpe.2021.108193.
2. Bernat J. L. (2020). Ethical Justifications for Pandemic Rationing Strategies. Annals of neurology, 88(3), 433–435. https://doi.org/10.1002/ana.25848.
3. Bruckhaus, A. A., Abedi, A., Salehi, S., Pickering, T. A., Zhang, Y., Martinez, A., Lai, M., Garner, R., & Duncan, D. (2021). COVID-19 Vaccination dynamics in the US: Coverage velocity and carrying capacity based on Socio-demographic Vulnerability indices in California. Journal of Immigrant and Minority Health, 24(1), 18–30. https://doi.org/10.1007/s10903-021-01308-2.
4. CDC (Centers for Disease Control and Prevention) (2020b). December 19 and 20, 2020 Presentation Slides. https://www.cdc.gov/vaccines/acip/meetings/slides-2020-12-19-20.html.
5. Chapman, L. A. C., Shukla, P., Rodríguez-Barraquer, I., Shete, P. B., León, T. M., Bibbins-Domingo, K., Rutherford, G. W., Schechter, R., & Lo, N. C. (2022). Risk factor targeting for vaccine prioritization during the COVID-19 pandemic. Scientific reports, 12(1), 3055. https://doi.org/10.1038/s41598-022-06971-5.